Results 131 to 140 of about 154,598 (309)

Targeting DNGR‐1 with Fangchinoline Elevates Dendritic Cell Antigen Cross‐Presentation‐Mediated Antitumor Immunity in Melanoma

open access: yesAdvanced Science, EarlyView.
Fangchinoline is identified as a small‐molecule DNGR‐1 modulator that enhances dendritic‐cell cross‐presentation of tumor antigens. By engaging DNGR‐1 and activating Syk–Nox2 signaling, it promotes phagosomal ROS, antigen escape, MHC‐I presentation, and CD8+ T‐cell priming, thereby strengthening antitumor immunity and sensitizing tumors to PD‐1 ...
Yuan Liao   +19 more
wiley   +1 more source

Patient PBMC differentiation to macrophages v1

open access: yes, 2023
Patient PBMC differentiation to macrophages
openaire   +1 more source

EGFP expression in PBMCs infected with H6R28LEP.

open access: yes, 2013
PBMCs were infected with H6R28LEP by using the centrifuge method and then were observed under polarizing microscopy (left) and fluorescent microscopy (right) at 4 d after infection.
Tadao Tanaka (104452)   +6 more
core   +1 more source

Expanded Hepatic Progenitor Cells Featured with Aggregation of α‐Synuclein Contribute to Pathologic Bile Duct Regeneration in Biliary Atresia

open access: yesAdvanced Science, EarlyView.
Expanded NCAM1+EpCAM+ hepatic progenitor cells in biliary atresia are characterized by aggregation of α‐synuclein. This pathological protein potentiates cellular susceptibility to GSH‐dependent redox dyshomeostasis, induces unstable biliary cell fate specification, and subsequently drives aberrant biliary regeneration.
Hua Xie   +12 more
wiley   +1 more source

Viral mRNA and protein expression in H6R28LEP-infected PBMCs.

open access: yes, 2013
A: PBMCs and CMBCs were infected with H6R28LEP, total RNA was purified after 24 h, and mRNA expression of immediate early (U90, U94), early (U41, U69), and late (U24, U39, U48) genes was assayed by real-time PCR after RT.
Tadao Tanaka (104452)   +6 more
core   +1 more source

Placental Site Trophoblastic Tumor Acquires Immune Functions by Incorporating Host Maternal Genes

open access: yesAdvanced Science, EarlyView.
PSTT cells, through cell fusion with B cells, incorporate abundant non‐inherited maternal genes that are detectable by DNIMA. These hybrid cells acquire immunotherapy‐resistant genetic changes and increase the expression of B cell‐derived immune‐related molecules such as Ig, HLA, LILRB, SIGLEC10, and so on, creating an immunotolerant environment around
Kyosuke Kagami   +15 more
wiley   +1 more source

CCR2+ PBMCs in ALS patients with varying clinical characteristics.

open access: yes, 2013
(A) Percentage (%) of PBMCs expressing CCR2 protein in ALS patients with mild, moderate and severe neurological impairments as indicated by ALSFRS-R. (B) Count (%) of CCR2+ PBMCs in ALS subjects with disease duration (DD) ≤19 months and DD>19 months. (C)
Akshay Anand (118579)   +3 more
core   +1 more source

Single‐Cell RNA Editing Identifies T Cell ADAR1 as a Key Regulator of Immune Exhaustion and Anti‐PD‐1 Resistance in Colorectal Cancer

open access: yesAdvanced Science, EarlyView.
Single‐cell RNA editing analysis identifies ADAR1 as a regulator of dysfunctional T cell states in colorectal cancer. Elevated ADAR1 activity promotes T cell exhaustion and impairs antitumor immunity partly through TGF‐β‐SMAD signaling, contributing to anti‐PD‐1 resistance and highlighting T cell ADAR1 as a potential therapeutic target and biomarker ...
Da Kang   +10 more
wiley   +1 more source

CITE-Seq PBMCs with demultiplexing v1

open access: yes, 2021
Total-Seq labelling with demultiplexing This protocol reflects a common experimental design where PBMC samples from multiple human donors are pooled together for Total-Seq (CITE-Seq) labelling. Often multiple samples from the same donor are to be profiled. An example is timepoint or treatment. Therefore we utilise 2 levels of multiplexing The distinct
openaire   +1 more source

Inhibition of KDEL Receptors Remodels the Tumor Microenvironment for T Cell Independent Tumor Regression

open access: yesAdvanced Science, EarlyView.
Inhibition of KDELR2 in a small fraction of tumor cells generates sustainable immunogenic cell death conditions within the tumor microenvironment. These conditions promote the regression of tumors in a T cell independent manner. During regression, macrophages prime T cells that subsequently provide systemic protection against recurrence. The potency of
Shakti P Pattanayak   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy